This shows you the differences between two versions of the page.
Next revision | Previous revision | ||
bacteria:t3e:xopj5 [2020/04/23 21:39] – external edit 127.0.0.1 | bacteria:t3e:xopj5 [2025/02/13 11:49] (current) – jfpothier | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== XopJ5 ====== | + | ====== |
- | Author: Alexandre B. de Menezes\\ | + | Author: |
- | Internal reviewer: | + | Internal reviewer: |
- | Expert reviewer: FIXME | + | |
- | Class: | + | Class: |
- | Family: | + | Family: |
- | Prototype: | + | Prototype: |
- | RefSeq | + | GenBank |
+ | RefSeq ID: [[https:// | ||
+ | Synonym: AvrXccB\\ | ||
3D structure: Unknown | 3D structure: Unknown | ||
===== Biological function ===== | ===== Biological function ===== | ||
- | In // | + | In // |
=== How discovered? === | === How discovered? === | ||
- | Original discovery was through bioinformatic predictions and comparative genomics of // | ||
+ | Original discovery was through bioinformatic predictions and comparative genomics of // | ||
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
- | T3E-defective mutant was not capable of secreting the effector protein when carrying the plasmid-borne gene encoding for AvrXccB. | ||
+ | Using the HR-inducing domain AvrBs1< | ||
+ | |||
+ | AvrXccB, fused to a HA tag, was shown to be secreted into culture supernatants by Western blot analysis using an anti‐haemagglutinin (HA) antibody. In contrast, a T3E-defective mutant was not capable of secreting this effector (Liu //et al//., 2017). | ||
=== Regulation === | === Regulation === | ||
- | HrpG and HrpX (Jiang //et al//., 2009; Rongqi //et al//., 2009). | ||
+ | The //xopE1// < | ||
=== Phenotypes === | === Phenotypes === | ||
- | AvrXccB is not essential | + | |
+ | * AvrXccB | ||
+ | * XopJ5 was found to be associated with variations in disease symptoms when testing a set of 45 //X. campestris// | ||
+ | * Experimental evidence using heterologous expression of // | ||
=== Localization === | === Localization === | ||
- | Membrane, confirmed experimentally through GFP tagged AvrXccB expression in transgenic // | + | |
+ | Plant plasma membrane, confirmed experimentally through GFP-tagged AvrXccB expression in transgenic // | ||
=== Enzymatic function === | === Enzymatic function === | ||
- | Cysteine protease/ | + | |
+ | Cysteine protease/ | ||
=== Interaction partners === | === Interaction partners === | ||
- | AvrXccB interacts with SAM-MT1 in // | + | |
+ | AvrXccB interacts | ||
===== Conservation ===== | ===== Conservation ===== | ||
=== In xanthomonads === | === In xanthomonads === | ||
- | Yes. YojP-like effectors such as AvrBsT in Xcv or Xcc, XopJ in Xcv. | + | |
+ | Yes. YopJ-like effectors such as AvrBsT in //Xcv// or //Xcc//, XopJ in //Xcv//. | ||
=== In other plant pathogens/ | === In other plant pathogens/ | ||
- | Yes. YojP-like effectors HopZ1a in //P. syringae// and Pop2 in //R. solanacearum// | + | |
+ | Yes. YopJ-like effectors HopZ1a in //P. syringae// and Pop2 in //R. solanacearum// | ||
===== References ===== | ===== References ===== | ||
- | da Silva ACR, Ferro JA, Reinach FC, //et al//. (2002). Comparison of the genomes of two // | + | da Silva AC, Ferro JA, Reinach FC, Farah CS, Furlan LR, Quaggio RB, Monteiro-Vitorello CB, Van Sluys MA, Almeida NF, Alves LM, do Amaral AM, Bertolini MC, Camargo LE, Camarotte G, Cannavan F, Cardozo J, Chambergo F, Ciapina LP, Cicarelli RM, Coutinho LL, Cursino-Santos JR, El-Dorry H, Faria JB, Ferreira AJ, Ferreira RC, Ferro MI, Formighieri EF, Franco MC, Greggio CC, Gruber A, Katsuyama AM, Kishi LT, Leite RP, Lemos EG, Lemos MV, Locali EC, Machado MA, Madeira AM, Martinez-Rossi NM, Martins EC, Meidanis J, Menck CF, Miyaki CY, Moon DH, Moreira LM, Novo MT, Okura VK, Oliveira MC, Oliveira VR, Pereira HA, Rossi A, Sena JA, Silva C, de Souza RF, Spinola LA, Takita MA, Tamura RE, Teixeira EC, Tezza RI, Trindade dos Santos M, Truffi D, Tsai SM, White FF, Setubal JC, Kitajima JP (2002). Comparison of the genomes of two // |
+ | |||
+ | Guy E, Genissel A, Hajri A, Chabannes M, David P, Carrere S, Lautier M, Roux B, Boureau T, Arlat M, Poussier S, Noël LD (2013). Natural genetic variation of // | ||
+ | |||
+ | Jiang W, Jiang BL, Xu RQ, Huang JD, Wei HY, Jiang GF, Cen WJ, Liu J, Ge YY, Li GH, Su LL, Hang XH, Tang DJ, Lu GT, Feng JX, He YQ, Tang JL (2009). Identification of six type III effector genes with the PIP box in // | ||
+ | |||
+ | Liu L, Wang Y, Cui F, Fang A, Wang S, Wang J, Wei C, Li S, Sun W (2017). The type III effector AvrXccB in // | ||
- | Jiang W, Jiang B-L, Xu R-Q, //et al//. (2009). Identification | + | Rongqi X, Xianzhen L, Hongyu |
- | Rongqi X, Xianzhen L, Hongyu W, //et al//. (2006). Regulation of eight avr by hrpG and hrpX in // | + | Thieme F, Szczesny R, Urban A, Kirchner O, Hause G, Bonas U (2007). New type III effectors from // |
- | Thieme F, Szczesny R, Urban A, Kirchner O, Hause G, Bonas U (2007). New Type III Effectors from // | + | ===== Acknowledgements ===== |
- | Wang S, Fang A, Liu L, //et al//. (2016). The type III effector AvrXccB | + | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation |